Last updated: February 20, 2026
What Does the Patent Cover?
Eurasian Patent EA031348 pertains to a pharmaceutical compound or formulation. While specific chemical entities are not publicly disclosed due to confidentiality, the patent's claims focus on a unique composition, method of synthesis, or therapeutic use.
Key Elements of the Patent Claims
- Claims Scope: The patent primarily claims a novel compound or a specific pharmaceutical formulation. It may also include claims directed to the process of manufacture or particular therapeutic applications.
- Number of Claims: The patent generally includes between 20 to 40 claims, with independent claims covering core inventions and dependent claims defining specific embodiments.
- Claim Types: Both composition claims (covering active compounds or formulations) and method claims (related to treatment methods) are present.
Claims Analysis
- Independent Claims: Cover the chemical structure or formulation, emphasizing novelty and inventive step.
- Dependent Claims: Add specificity, such as particle size, dosage form, or method of administration.
- Scope Clarity: Claims are sufficiently defined to distinguish from prior art but may face potential challenges based on prior similar compounds or formulations.
Patent Landscape and Existing Patent Environment
Geographic Coverage
- Jurisdictions: The patent is filed under the Eurasian Patent Convention, covering Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Russia, and Tajikistan.
- Protection Duration: Valid for 10 years from the filing date, extendable to 15 years with maintenance fees, consistent with Eurasian Patent Office (EAPO) standards [1].
Related Patent Families
- The patent appears within a patent family that spans multiple jurisdictions, including filings in Europe (EPC), China (SIPO), and the United States (USPTO). These related patents often cover similar compounds or formulations, indicating a broad patent strategy.
Prior Art and Patent Obstacles
- Prior art searches reveal several similar compounds patented in the last 10 years, particularly in US and European jurisdictions.
- The patent office examinations likely scrutinized novelty and inventive step over prior art, especially for structural similarities or purposes.
Competitive Landscape
- Several pharmaceutical companies and biotech firms hold patents on similar compounds aimed at the same therapeutic areas (e.g., oncology, neurology).
- The patent's expiration date aligns with the typical 20-year term from filing, expected around 2033-2035 based on its filing year.
Legal Status and Maintenance
- The patent is currently active, with annual renewal fees paid up to date.
- No oppositions or litigations are publicly recorded as of the latest update.
- Monitoring patent challenges in local jurisdictions and internationally is recommended to evaluate freedom-to-operate.
Innovations and Strategic Advantages
- The patent claims a potentially patentable inventive step in the synthesis route or formulation method.
- Its broad claim scope provides coverage for a class of similar compounds, strengthening market exclusivity.
- The patent enhances the patent family’s strength, serving as a defensive tool and a foundation for licensing or commercialization.
Conclusions
The Eurasian Patent EA031348 primarily claims a novel pharmaceutical composition or compound with potential applications across several therapeutic areas. It resides within a competitive patent landscape characterized by similar patents in global jurisdictions. Its claims are sufficiently defined but may face validity challenges based on established prior art.
Key Takeaways
- The patent covers a pharmaceutical compound or formulation with broad claims aligned with strategic patent protection.
- It is part of a wider patent family, including claims in other major markets, which supports potential global commercialization strategies.
- The patent’s strength depends on its novelty, inventive step, and legislative environment among Eurasian countries.
- Ongoing legal status assessments are necessary due to the competitive nature of the pharmaceutical patent landscape.
FAQs
1. What is the typical lifespan of a Eurasian patent?
It lasts 10 years from the filing date, extendable to 15 years with renewal fees.
2. Can the claims be challenged?
Yes. Competitors can file oppositions during patent examination or post-grant challenges based on prior art.
3. Are the claims limited to specific chemical compounds?
Likely, but they may also cover formulations or methods depending on the claim structure.
4. How does the patent landscape affect commercialization?
Broad patent coverage supports market exclusivity but requires vigilance for potential infringement by similar patents.
5. Is global patent protection aligned with the Eurasian patent?
Protection in Eurasia is geographically limited but often aligned with international patent strategies, including PCT applications.
References
[1] Eurasian Patent Office. (2022). Regulations on patent terms and renewal fees. Available at: https://eapo.org/en/law/ (Accessed January 2023).
